Quantinno Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.13M Buy
127,400
+58,352
+85% +$2.23M ﹤0.01% 1596
2026
Q2
$2.57M Buy
69,048
+3,304
+5% +$107K ﹤0.01% 1750
2026
Q1
$2.09M Buy
65,744
+42,158
+179% +$1.15M ﹤0.01% 1602
2025
Q4
$641K Buy
+23,586
New +$621K ﹤0.01% 2168

Other funds holding CLDX

Quantinno Capital Management's CLDX Position: Q3 2026 in Review

Quantinno Capital Management increased its Celldex Therapeutics (CLDX) stake by 85% in Q3 2026, buying an estimated $2.23M and bringing the position to 127,400 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Quantinno Capital Management first reported a position in CLDX in Q4 2025 and has held it in 4 quarters since. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.

  • Quantinno Capital Management held 127,400 shares of Celldex Therapeutics worth $4.13M as of Q3 2026.
  • Quantinno Capital Management bought 58,352 Celldex Therapeutics shares in Q3 2026, an estimated $2.23M.
  • Celldex Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1596 holding.
  • Quantinno Capital Management first reported a position in Celldex Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.